Literature DB >> 7512994

Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia.

E M O'Callaghan1, M S Tanner, G J Boulnois.   

Abstract

AIMS: To develop a system of species specific polymerase chain reaction (PCR) and DNA hybridisation based on 16s ribosomal RNA sequences for the identification of Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia in sputum from children with cystic fibrosis.
METHODS: Most of the 16s rRNA sequences from strains of Ps aeruginosa, Ps (Burkholderia) cepacia, and Ps putida were determined. PCR primers and DNA probes were synthesised from suitable sequences and then evaluated on bacterial cultures and sputum samples.
RESULTS: About 1000 bases of sequence was obtained from strains of Ps aeruginosa, Ps (Burkholderia) cepacia, and Ps putida. PCR of bacterial cultures was species specific, but PCR on sputum resulted in some non-specific amplification products. The subsequent hybridisation reaction was species specific.
CONCLUSION: A species specific system of PCR and DNA hybridisation based on 16s rRNA sequences is applicable in clinical practice, and may aid the early diagnosis of respiratory tract infection with small numbers of Ps aeruginosa and Ps (Burkholderia) cepacia in patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512994      PMCID: PMC501899          DOI: 10.1136/jcp.47.3.222

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses.

Authors:  D J Lane; B Pace; G J Olsen; D A Stahl; M L Sogin; N R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 2.  Bacterial evolution.

Authors:  C R Woese
Journal:  Microbiol Rev       Date:  1987-06

3.  Oligonucleotide probes complementary to variable regions of ribosomal RNA discriminate between Mycoplasma species.

Authors:  U B Göbel; A Geiser; E J Stanbridge
Journal:  J Gen Microbiol       Date:  1987-07

4.  Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71.

Authors:  M B Mearns; G H Hunt; R Rushworth
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

5.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

6.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

7.  Detection of Mycobacterium tuberculosis in clinical samples by two-step polymerase chain reaction and nonisotopic hybridization methods.

Authors:  R M Shawar; F A el-Zaatari; A Nataraj; J E Clarridge
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

8.  Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.

Authors:  M J Thomassen; C A Demko; J D Klinger; R C Stern
Journal:  Am Rev Respir Dis       Date:  1985-05

9.  Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.

Authors:  O C Tablan; W J Martone; C F Doershuk; R C Stern; M J Thomassen; J D Klinger; J W White; L A Carson; W R Jarvis
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

10.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more
  11 in total

1.  Identification of members of the Burkholderia cepacia complex by species-specific PCR.

Authors:  P W Whitby; K B Carter; K L Hatter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 2.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Direct PCR detection of Burkholderia cepacia complex and identification of its genomovars by using sputum as source of DNA.

Authors:  Pavel Drevínek; Hana Hrbácková; Ondrej Cinek; Jana Bartosová; Otakar Nyc; Alexandr Nemec; Petr Pohunek
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

4.  Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility.

Authors:  Annamaria Bevivino; Claudia Dalmastri; Silvia Tabacchioni; Luigi Chiarini; Maria L Belli; Sandra Piana; Alberto Materazzo; Peter Vandamme; Graziana Manno
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.

Authors:  C van Pelt; C M Verduin; W H Goessens; M C Vos; B Tümmler; C Segonds; F Reubsaet; H Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.

Authors:  J J LiPuma; B J Dulaney; J D McMenamin; P W Whitby; T L Stull; T Coenye; P Vandamme
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Real-time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR).

Authors:  R I Jaffe; J D Lane; C W Bates
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

8.  Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.

Authors:  M R Shreve; S Butler; H J Kaplowitz; H R Rabin; D Stokes; M Light; W E Regelmann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers.

Authors:  S D Tyler; C A Strathdee; K R Rozee; W M Johnson
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

10.  Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients.

Authors:  Pieter Deschaght; Thierry De Baere; Leen Van Simaey; Sabine Van Daele; Frans De Baets; Daniel De Vos; Jean-Paul Pirnay; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2009-11-29       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.